These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 37885170)

  • 1. Editorial: PPIs and gastric cancer-Are we dealing with a carcinogen?
    Malfertheiner P; Schulz C; Howden CW
    Aliment Pharmacol Ther; 2023 Nov; 58(10):1099-1100. PubMed ID: 37885170
    [No Abstract]   [Full Text] [Related]  

  • 2. Long-term proton pump inhibitors and risk of gastric cancer development after treatment for
    Cheung KS; Chan EW; Wong AYS; Chen L; Wong ICK; Leung WK
    Gut; 2018 Jan; 67(1):28-35. PubMed ID: 29089382
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proton pump inhibitors and gastric cancer: a population-based cohort study.
    Patel J; Berezowski I; Janapala RN; Pourmand A
    Gut; 2022 May; 71(5):1039-1041. PubMed ID: 34261754
    [No Abstract]   [Full Text] [Related]  

  • 4. Haemorrhagic gastric hyperplastic polyps associated with long-term use of proton pump inhibitor in a case without Helicobacter pylori infection.
    Kinoshita S; Nishizawa T; Mori H; Kikuchi M
    J Clin Pharm Ther; 2019 Jun; 44(3):493. PubMed ID: 30773665
    [No Abstract]   [Full Text] [Related]  

  • 5. OLGIM staging and proton pump inhibitor use predict the risk of gastric cancer.
    Arai J; Niikura R; Hayakawa Y; Aoki T; Yamada A; Kawai T; Fujishiro M
    Gut; 2022 May; 71(5):1043-1044. PubMed ID: 34344784
    [No Abstract]   [Full Text] [Related]  

  • 6. Association between proton pump inhibitor use and gastric cancer: a population-based cohort study using two different types of nationwide databases in Korea.
    Seo SI; Park CH; You SC; Kim JY; Lee KJ; Kim J; Kim Y; Yoo JJ; Seo WW; Lee HS; Shin WG
    Gut; 2021 Nov; 70(11):2066-2075. PubMed ID: 33975868
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sporadic fundic gland polyps are not associated with proton pump inhibitors therapy but negatively correlate with Helicobacter pylori infection in China.
    Cao H; Qu R; Zhang Z; Kong X; Wang S; Jiang K; Wang B
    Chin Med J (Engl); 2014; 127(7):1239-43. PubMed ID: 24709173
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proton pump inhibitors (PPIs) may cause gastric cancer - clinical consequences.
    Waldum HL; Sørdal Ø; Fossmark R
    Scand J Gastroenterol; 2018 Jun; 53(6):639-642. PubMed ID: 29852782
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Can We StoP Worrying about Long-term PPIs and Gastric Cancer Risk?
    Richman CM; Leiman DA
    Cancer Epidemiol Biomarkers Prev; 2023 Sep; 32(9):1127-1129. PubMed ID: 37655427
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relative risk factors associated with the development of fundic gland polyps.
    Huang CZ; Lai RX; Mai L; Zhou HL; Chen HJ; Guo HX
    Eur J Gastroenterol Hepatol; 2014 Nov; 26(11):1217-21. PubMed ID: 25187299
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Editorial: PPIs and gastric cancer - Are we dealing with a carcinogen? Authors' reply.
    Gong EJ; Jung HK
    Aliment Pharmacol Ther; 2023 Nov; 58(10):1101-1102. PubMed ID: 37885162
    [No Abstract]   [Full Text] [Related]  

  • 12. Relationship between long-term use of proton pump inhibitors and risk of gastric cancer: A systematic analysis.
    Jiang K; Jiang X; Wen Y; Liao L; Liu FB
    J Gastroenterol Hepatol; 2019 Nov; 34(11):1898-1905. PubMed ID: 31206764
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of Proton Pump Inhibitors and Risks of Fundic Gland Polyps and Gastric Cancer: Systematic Review and Meta-analysis.
    Tran-Duy A; Spaetgens B; Hoes AW; de Wit NJ; Stehouwer CD
    Clin Gastroenterol Hepatol; 2016 Dec; 14(12):1706-1719.e5. PubMed ID: 27211501
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acid-suppressing therapies and subsite-specific risk of stomach cancer.
    Wennerström ECM; Simonsen J; Camargo MC; Rabkin CS
    Br J Cancer; 2017 Apr; 116(9):1234-1238. PubMed ID: 28350791
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk factors for gastric cancer: is it time to discard PPIs?
    Laterza L; Scaldaferri F; Gasbarrini A
    Gut; 2019 Jan; 68(1):176-177. PubMed ID: 29331945
    [No Abstract]   [Full Text] [Related]  

  • 16. Use of proton pump inhibitors for the risk of gastric cancer.
    Gao H; Li L; Geng K; Teng C; Chen Y; Chu F; Zhao Y
    Medicine (Baltimore); 2022 Dec; 101(49):e32228. PubMed ID: 36626449
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of Proton Pump Inhibitors vs Histamine 2 Receptor Antagonists for the Risk of Gastric Cancer: Population-Based Cohort Study.
    Shin GY; Park JM; Hong J; Cho YK; Yim HW; Choi MG
    Am J Gastroenterol; 2021 Jun; 116(6):1211-1219. PubMed ID: 34074826
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Duration of use of proton pump inhibitors and the risk of gastric and oesophageal cancer.
    Brusselaers N; Lagergren J; Engstrand L
    Cancer Epidemiol; 2019 Oct; 62():101585. PubMed ID: 31445426
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proton pump inhibitors and risk of gastric cancer: population-based cohort study.
    Abrahami D; McDonald EG; Schnitzer ME; Barkun AN; Suissa S; Azoulay L
    Gut; 2022 Jan; 71(1):16-24. PubMed ID: 34226290
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proton pump inhibitors and gastric cancer.
    Waldum HL
    Tidsskr Nor Laegeforen; 2016 Jan; 136(1):13-4. PubMed ID: 26757651
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.